Intestinal permeability — colloquially called "leaky gut" — is one of the most discussed and least precisely tested conditions in functional medicine. The problem isn't that it's not real. It is. The problem is that most "leaky gut tests" sold online measure surrogate markers with questionable clinical validity. Here's what the evidence actually supports.
The intestinal epithelium is a single-cell-layer barrier separating your gut lumen from your body's immune system. These cells are held together by tight junction proteins — claudins, occludins, and zonula occludens. When these proteins degrade, gaps form between cells, allowing bacterial endotoxins (LPS), undigested food particles, and microorganisms to translocate into systemic circulation.
This translocation triggers a chronic low-grade inflammatory response that's implicated in autoimmune conditions, metabolic disease, depression, and fatigue. The challenge is that "leaky gut" as a symptom presentation overlaps with dozens of other conditions.
The lactulose/mannitol test is the gold standard for intestinal permeability assessment in research settings. You drink a measured solution of lactulose (a large disaccharide) and mannitol (a small monosaccharide), then collect urine for 5–24 hours.
Mannitol crosses the gut wall easily in healthy intestines. Lactulose normally does not. An elevated lactulose/mannitol ratio indicates paracellular permeability — gaps between cells.
Reference range: L/M ratio <0.04 is normal. >0.07 suggests significant permeability.
Zonulin is a protein that regulates tight junction opening. Elevated serum or stool zonulin indicates active tight junction disruption. It's the most commonly ordered functional medicine marker for permeability.
Caveat: Zonulin assays have significant variability between labs. Serum complement C3 — which many zonulin antibodies cross-react with — can produce false positives. Stool zonulin is more specific than serum.
Lipopolysaccharide (LPS) is an endotoxin from gram-negative bacteria. When gut permeability increases, LPS translocates into blood. LPS-binding protein (LBP) is an acute-phase reactant that binds LPS and is a sensitive marker of endotoxemia.
Elevated LBP (>8.2 μg/mL) in the absence of acute infection suggests chronic low-grade endotoxemia from intestinal permeability.
I-FABP is released from damaged intestinal epithelial cells into circulation. It's highly specific to intestinal injury and is elevated in celiac disease, Crohn's disease, and significant permeability events. It's less useful for subclinical permeability than zonulin or LBP.
Calprotectin is a calcium-binding protein released by activated neutrophils in the intestinal mucosa. Elevated fecal calprotectin (>50 μg/g) indicates intestinal inflammation, which is almost always accompanied by permeability. It's the most clinically accepted test and used by gastroenterologists to differentiate IBD from IBS.
| Test | What It Measures | Best For | Where to Order |
|---|---|---|---|
| L/M Ratio | Paracellular permeability | Direct permeability measurement | Genova, Doctor's Data |
| Zonulin (stool) | Tight junction regulation | Functional medicine workup | Genova GI Effects |
| LBP (serum) | Systemic endotoxemia | Metabolic/inflammatory workup | Quest, LabCorp |
| I-FABP (serum) | Epithelial cell damage | Acute mucosal injury | Specialty labs |
| Calprotectin (stool) | Mucosal inflammation | IBD vs IBS differentiation | Any GI lab panel |
As an Amazon Associate, GutCode earns from qualifying purchases made through links on this page. This does not affect the price you pay.